What companies are ERAS's competitors?

Erasca, Inc. (ERAS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does ERAS compare to its peers?

The peer comparison table on this page shows Erasca, Inc. (ERAS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does ERAS operate in?

Erasca, Inc. (ERAS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

ERAS

Erasca, Inc.

NASDAQ·Biotechnology · Healthcare

$14.39$0.35+2.49%

Market cap$5.03B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About ERAS

What companies are ERAS's competitors?: Erasca, Inc. (ERAS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ERAS compare to its peers?: The peer comparison table on this page shows Erasca, Inc. (ERAS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ERAS operate in?: Erasca, Inc. (ERAS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

ERAS

Erasca, Inc.

NASDAQ·Biotechnology · Healthcare

$14.39$0.35+2.49%

Market cap$5.03B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


RVMDRVMDRevolution Medicines, Inc.	Revolution Medicines, Inc.	$186.99	$40.1B
TNGXTNGXTango Therapeutics, Inc.	Tango Therapeutics, Inc.	$23.34	$3.9B
IDYAIDYAIDEAYA Biosciences, Inc.	IDEAYA Biosciences, Inc.	$34.71	$3.3B
NUVBNUVBNuvation Bio Inc.	Nuvation Bio Inc.	$4.57	$1.6B
ORICORICORIC Pharmaceuticals, Inc.	ORIC Pharmaceuticals, Inc.	$13.17	$1.4B
AVBPAVBPArriVent BioPharma, Inc.	ArriVent BioPharma, Inc.	$21.00	$1.0B
VSTMVSTMVerastem, Inc.	Verastem, Inc.	$10.04	$909.3M
KURAKURAKura Oncology, Inc.	Kura Oncology, Inc.	$9.61	$854.9M
CRISCRISCuris, Inc.	Curis, Inc.	$0.39	$753.3K

Frequently Asked Questions About ERAS

What companies are ERAS's competitors?: Erasca, Inc. (ERAS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ERAS compare to its peers?: The peer comparison table on this page shows Erasca, Inc. (ERAS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ERAS operate in?: Erasca, Inc. (ERAS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.